Citius Pharma (NASDAQ:CTXR) reported quarterly earnings results on February 13, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share of…
Citius Pharma (NASDAQ:CTXR) reported quarterly earnings results on February 13, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.38, missing the consensus estimate of $-0.30 by $0.08 per share. Revenue came in at $3.9M, beating the estimate of $3.5M.
Citius Pharma's stock moved following the earnings release. The stock currently trades at $0.77 with a market capitalization of $13.0M.
Current market data
NASDAQ · CTXR
$0.59
Up: +$0.00 · +0.57%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
earnings ·
earnings ·
sec_filing ·
sec_filing ·
